BL
HQH

Balentine LLC’s abrdn Healthcare Investors HQH Stock Holding History

Balentine LLC’s Portfolio HQH Stock Details HQH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,825
Closed -$60K – 473
2020
Q2 		$60K Buy
+2,825
New +$57.6K ﹤0.01% 216

Other funds holding HQH

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Balentine LLC's HQH Position: Q3 2020 in Review

Balentine LLC sold out of abrdn Healthcare Investors (HQH) in Q3 2020, closing a stake of 2,825 shares — an estimated $60K sold.

Balentine LLC first reported a position in HQH in Q2 2020 and held it in 1 quarter. The position peaked at $60K in Q2 2020. 97 funds tracked by Wall St. Rank hold HQH as of Q3 2020.

  • Balentine LLC reported no remaining abrdn Healthcare Investors position as of Q3 2020 after selling out during the quarter.
  • Balentine LLC sold 2,825 abrdn Healthcare Investors shares in Q3 2020, an estimated $60K.
  • Balentine LLC first reported a position in abrdn Healthcare Investors in Q2 2020 and held it in 1 quarter.
  • Balentine LLC's abrdn Healthcare Investors position peaked at $60K in Q2 2020.
  • 97 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q3 2020.

Based on Balentine LLC's 13F filing for Q3 2020, filed 2 Nov 2020.